Researchers
in Gordon's lab describe their findings in the March 31 issue
of Proceedings of the National Academy of Sciences. First authors
are postdoctoral fellow Janaki L. Guruge, Ph.D., and Per Falk,
M.D., Ph.D., adjunct assistant professor of molecular biology
and pharmacology at the School of Medicine and now associate director
of molecular biology at the Swedish pharmaceutical company ASTRA
Hässle.
Half of the world's people are colonized with Helicobacter
pylori. Most have few symptoms -- some gastric inflammation, perhaps,
before an apparently harmonious relationship sets in that can
last for decades. But 10 to 20 percent of people infected with
Helicobacter phylori are not so lucky. Some get ulcers, and others
develop progressive inflammation of the stomach and lose acid-producing
cells. This increases their risk for stomach cancer, which is
common in countries where Helicobacter pylori infection is rife.
"This
is a rather extraordinary example of a bacterium that can be relatively
harmless in some people and cause cancer in others," Gordon
says. "The challenge is to identify patients who are at risk
for developing more serious disease."
Look
into the stomach of an infected person who has severe gastritis
or ulcers, and you'll see Helicobacter pylori associated with
cells that line the stomach. The bacterium is able to produce
molecules that allow it to attach to these stomach cells. In laboratory
experiments, scientists have identified several molecular receptors
that can serve as potential sites for Helicobacter pyloril attachment.
"We wanted to find out whether -- and how -- attachment could
alter the outcome of infection," Gordon says.
Australian scientists fingered Helicobacter pylori as the culprit
of peptic ulcers in the 1980s, but the lack of genetically well-defined
animal models has hampered attempts to understand how the organism
causes disease. "Cultured stomach cells can't reveal how
you would respond if Helicobacter pylori stuck to your stomach
lining," Falk says.
In 1993, Falk and another Swedish scientist at Washington University,
Thomas Borén, D.D.S., Ph.D., discovered that Helicobacter pylori
can attach to a molecule called Lewis b (Leb) on stomach lining
cells. This molecule also decorates the red blood cells of people
with the Leb blood group.
In Gordon's lab, Falk introduced the human Leb gene into a
mouse. He manipulated the gene so it was produced in cells that
line the animal's stomach. Mice without the human Leb gene
served as normal controls.
Both groups of mice were exposed to Helicobacter pylori strains
retrieved from Peruvian patients with gastritis. The Leb blood
group antigen is commonly found in Peruvians, and most Helicobacter
pylori strains from Peru are able to bind to Leb. Guruge found
that both groups of mice -- those with and those without Leb --
became infected with Helicobacter pylori easily and for long periods
of time. The bacteria attached to the stomach epithelium only
in animals with human Leb, however. In the control mice that lacked
Leb, they simply parked in the gastric mucus.
This difference in location affected the mouse's immune response.
Guruge noticed that the mouse made antibodies against Helicobacter
pylori carbohydrates when the bacterium attached to the stomach
lining. As it turned out, these bacterial carbohydrates resembled
carbohydrates that a mouse's own acid-producing parietal cells
normally produce.
Faced with this molecular mimicry, the immune system attacked
the mouse's own acid-producing cells as well as the bacteria.
The Leb mice developed an inflammatory reaction that resembled
chronic active gastritis found in humans with symptomatic Helicobacter
pylori infection. Their parietal cells disappeared, as they do
in humans with atrophic gastritis, a precancerous condition. In
a different study, Gordon's group has shown that undifferentiated
cells in the stomach lining proliferate abnormally when parietal
cells are lost. Such unrestrained cell division eventually may
increase the risk of cancer, Gordon suggests. "So though attachment
isn't necessary for Helicobacter pylorii infection, it markedly
affects the outcome of infection," he says.
This genetically well-defined model should enable researchers
to identify bacterial and host genes that respond to attachment.
Such information should further treatment and prevention efforts.
Gordon suggests that his group's approach also could be used
with other types of bacteria to understand the role of bacterial
attachment in a variety of diseases. "This melding of transgenic
mice and molecular microbiology offers great opportunities for
the future," he says.
Guruge JL, Falk PG, Lorenz RG, Dans M, Wirth H-P, Blaser MJ, Berg
DE, Gordon JI. Epithelial attachment alters the outcome of Helicobacter
pylori infection. Proceedings of the National Academy of Sciences,
95, 3925-3930, 1998
This research on Helicobacter phylori was supported by grants
from the National Institutes of Health and the Swedish Cancer
Society.
Note:
This article on Helicobacter phylori has been adapted from
a news release issued by Washington University School Of Medicine
for journalists and other members of the public. If you wish to
quote from any part of this story, please credit Washington University
School Of Medicine as the original source.
This article on Helicobacter phylori was published by Science
Daily, www.sciencedaily.com.
Comment:
We
have published this article on Helicobacter pylori because we
think it gives insight into how intestinal bacteria operate. Sally
Robertson
Next - Back
to Bacteria and Intestines Rsearch